Figure 5. Antitumor activity of scriptaid in an HCC xenograft model.
(A,B) Representative image of xenograft tumors from BALB/c nude mice subcutaneously injected with HepG2 cells and treated with PBS or scriptaid twice a week. (C,D) Primary tumor weights and volumes in BALB/c nude mice that received scriptaid treatment. Error bars: mean + S.D. (n=6). *, P<0.05.